THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing novel cell therapies for multiple sclerosis (MS), today reported financial results for the quarter ended June 30, 2008, and provided an update on its recent accomplishments.
